Impact of Local and Demographic Factors on Early COVID-19 Vaccine Hesitancy among Health Care Workers in New York City Public HospitalsArticle Published on 2022-02-102022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] affecting Analysis applied Care conducted contribute COVID-19 COVID-19 vaccine demographic demographic factor determine Effective vaccines examined Factor Factors Health Healthcare professional Healthcare workers Hesitancy hospital Impact influence information Local location machine New York City pandemic Predictive professional Public responses SARS-CoV-2 severity significantly Spread the vaccine vaccination Vaccine Vaccine attitudes Vaccine hesitancy worker [DOI] 10.3390/vaccines10020273 PMC 바로가기 [Article Type] Article
Knowledge, Attitudes, and Practices of Healthcare Workers in Jordan towards the COVID-19 VaccinationArticle Published on 2022-02-092022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] accounted Analysis COVID-19 COVID-19 vaccine cross-sectional demonstrated discrepancy doses Effectiveness Efficacy Factor females Final HCW HCWs Healthcare system healthcare worker Healthcare workers Hesitancy include independent Intervention investigated Jordan KAP knowledge lack Nurse Nurses Participants physician Physicians Practice public health questionnaire raise seasonal flu Side effect significantly higher significantly more the vaccine Vaccine Vaccine hesitancy women worker [DOI] 10.3390/vaccines10020263 PMC 바로가기 [Article Type] Article
The Landscape of COVID-19 Vaccination in Zimbabwe: A Narrative Review and Analysis of the Strengths, Weaknesses, Opportunities and Threats of the ProgrammeReview Published on 2022-02-092022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adverse outcome benefit country COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccination programme effort eligible Evidence Infectious disease International landscape Local narrative National opportunity population level public health policy reduce review shown the vaccine threat vaccinate vaccination Vaccine hesitancy variants of concern Zimbabwe [DOI] 10.3390/vaccines10020262 PMC 바로가기 [Article Type] Review
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individualsSARS-CoV-2 경험이 있는 개인에서 BNT162b2 mRNA 백신 1회 접종 후 강력한 면역 반응이 관찰됨Article Published on 2022-02-092022-09-12 Journal: Science Translational Medicine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] ASC BNT162b2 mRNA vaccination booster CD8 Cell Cohort coronavirus disease COVID-19 COVID-19 vaccine demonstrated diagnosis of COVID-19 dose Efficacy evaluated excluded first dose helping highlight humoral Humoral response immune response immunological implication increases in individual mRNA vaccination mRNA vaccine mRNA vaccines of BNT162b2 pandemic Prevent Protective regimen response robust second dose T cell response the vaccine These data Trial trials Vaccine [DOI] 10.1126/scitranslmed.abi8961 PMC 바로가기 [Article Type] Article
Do people reduce compliance with COVID-19 guidelines following vaccination? A longitudinal analysis of matched UK adultsOriginal Research Published on 2022-02-082022-10-29 Journal: Journal of epidemiology and community health [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] behavioural changes in comparable Compliance COVID-19 Covid-19 social study COVID-19 vaccine Effect Epidemics Evidence fixed group Health Immunity individual lifted lockdown restriction longitudinal analysis measure Measures receive receiving reduce reduced required Result risk second dose social distancing spread of COVID-19 study period the vaccine vaccinated individual vaccination virus was measured with COVID-19 [DOI] 10.1136/jech-2021-217179 PMC 바로가기 [Article Type] Original Research
COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment–Based Topic ModelingOriginal Paper Published on 2022-02-082022-10-30 Journal: Journal of Medical Internet Research [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] applied AstraZeneca automated calculated categories changed collected Community COVID-19 COVID-19 vaccine COVID-19 vaccines demonstrated determine distribution effective effort evaluate Evolution extreme heatmap help information Johnson & Johnson knowledge media modeling Moderna Neutral objective pandemic Pfizer positive programming promote Research Result sentiment evolution Side effect social media study period text mining the vaccine Topic topic modeling vaccinate vaccination Vaccine Vaccine hesitancy widespread [DOI] 10.2196/31726 PMC 바로가기 [Article Type] Original Paper
Understanding the dynamics of SARS-CoV-2 variants of concern in Ontario, Canada: a modeling study캐나다 온타리오주에서 우려되는 SARS-CoV-2 변종의 역학 이해: 모델링 연구Article Published on 2022-02-082022-09-10 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 변종, [키워드] acute respiratory syndrome Asymptomatic Booster vaccine Canada Care competition Computational biology and bioinformatics coronavirus coronavirus 2 Delta develop Diseases Effectiveness fraction Health Health care Health care system identify infect Inhibitory effects initial Intervention NPI outbreak respiratory reveal SARS-CoV-2 SARS-CoV-2 variant severe acute respiratory syndrome coronavirus 2 severity Spread strain Strains symptomatic infections the vaccine understanding vaccination vaccination rate Vaccine variant variants of concern VoC wild type wild-type [DOI] 10.1038/s41598-022-06159-x PMC 바로가기 [Article Type] Article
Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?Review Published on 2022-02-072022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] activate adjuvanticity advance antigen-presenting cell APC application approach Cancer vaccine Candidates cationic CD8+ T cells cell inactivation Complete COVID-19 cytosolic DASH Developing disciplinary Diseases effective effectively deliver Efficacy elicit elicited ENhance epitope etiological agent greater highlight Immunity in vitro inactivated inactivation Leishmania Leishmaniasis life-long immunity mechanism MHC molecule microbe Mouse models novel OVA ovalbumin pandemic Patient predicted previous study processed Produce PROTECT provide quest reactive resulting SARS-CoV-2 short-lived shown singlet oxygen spike protein-based vaccine Support suppress susceptible the disease the vaccine these cell Trigger urgency vaccination Vaccine Vaccines whole-cell vaccine platform [DOI] 10.3390/vaccines10020248 PMC 바로가기 [Article Type] Review
Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic reviewReview Published on 2022-02-072022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 치료기술, [키워드] approved AstraZeneca AztraZeneca biopsies biopsy caused changes in coronavirus Coronavirus disease 2019 COVID‐19 COVID‐19 COVID‐19 vacccine database death drug Efficacy and safety FDG fluorodeoxyglucose (FDG) PET‐CT scan food global pandemic help identify incidence injection ipsilateral janssen knowledge Lymph node Lymphadenopathy malignancies management Metastasis Moderna oncologist pathologic Patient patients Pfizer presenting Prevent radiologist reactive reported risk shown Side effect systematic literature search systematic review the vaccine tomography Transmission vaccination Vaccine was performed [DOI] 10.1002/jmv.27599 PMC 바로가기 [Article Type] Review
COVID-19 Vaccination Coverage in Patients with Rheumatic Diseases in a German Outpatient Clinic: An Observational StudyCommunication Published on 2022-02-072022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% CI 95% confidence interval age asked connective tissue disease Coverage COVID-19 COVID-19 pandemic COVID-19 vaccination effective first vaccination Infection Influenza majority medication Odds ratio Outpatient Patient patients pneumococcus Probability raise reason reported rheumatic disease Rheumatic diseases rheumatoid arthritis risk Safe SARS-CoV-2 SARS-CoV-2 vaccination severe COVID-19 Side effects spondyloarthritis Streptococcus pneumoniae susceptibility tested the vaccine unmet need vaccination vaccination rate vaccination rates Vaccine [DOI] 10.3390/vaccines10020253 PMC 바로가기 [Article Type] Communication